I. Introduction:
Scrub Typhus or tsutsugamushi disease is a febrile illness caused by bacteria of the family Rickettsiaceae and named Orientia tsutsugamushi. Recently it has been found to be endemic in Subhimalayan region of India. Even though the neurological manifestations of scrub typhus is known entity, presenting as focal neurological deficit was unknown 1, 3 till now only one case was reported in the English Literature 2 . So we are reporting a case of scrub typhus presenting as Focal Neurological deficit.
II.
Case Report: In view of high index of clinical suspicion, patient was subjected to Weil-Felix, IgM ELISA for scrub typhus which was showing OX-K2 titers of 1:320 in weil-felix & IgM Elisa for scrub typhus positivity.
Computed Tomography Scan of brain shows presence of hypo dense areas involving the bilateral basal ganglia with CT attenuation value of 15-22HU, possibility of encephalitis or infarct was kept.
Magnetic Resonance Imaging of brain shows altered signal intensity in areas involving the bilateral basal ganglia with lesion showing hyper intense on T1WI, T2WI & FLAIR. No evidence of restriction seen on Diffusion Weighted images. There is also evidence of altered Signal Intensities in areas involving bilateral internal capsule, around the basal ganglia, bilateral medial temporal lobes and inferior frontal lobe of anterior part of left midbrain(substantia nigra).These areas shows hypointense on T1WI, hyper intense on T2WI, FLAIR. Overall findings are suggestive of Japanese Encephalitis. But IgM serology for Japanese encephalitis was negative.
Cerebrospinal fluid analysis, Random blood sugar, Kidney function tests, Liver function tests and Electrolytes were within normal limits. On examination there was no evidence of any raised Intracranial pressure features or meningeal signs. Serum parameters for random blood sugar /electrolytes /urea/creatinine/calcium/arterial blood gas analysis were normal. Chest radiography did not show any evidence of aspiration or infection.
After the diagnosis of scrub typhus patient was stabilized with Intra Venous lines, nasogastric feeding/Foleys catheterization. As per the standard of care for the scrub typhus she was initiated on azithromycin intravenously 500mg once a day for 5 days and doxycycline 100mg twice a day for 14 days through NG tube, I/V dextrose and thiamine was given. Patient showed improvement in GCS scale, kps scale, and motor power improvement. Initially in antigravity muscles followed by recovery of Sensory symptoms, bowel and bladder system improvement. Improvement was started on day 3 rd day of azithromycin, in view of clinical recovery azithromycin was continued for another 2 days. At discharge patient was afebrile, was able to communicate with her attendants normally. Patient was discharged on day 14 th with complete recovery with no neurological deficit.
III. Discussion:
Increased prevalence of scrub typhus has been noted in the Asian subcontinents and tsutsugaushi triangle. It is endemic in certain geographic regions of India, Indonesia, Maldives, Mayanmar, Nepal, Srilanka and It divides and breeds within the phagocytes and escape from the cell back into the circulation to continue to proliferate on the endothelium of small blood vessels releasing cytokines which damage endothelial integrity, causing fluid leakage, platelet aggregation, polymorphs and monocyte proliferation, leading to focal occlusive end-angiitis causing micro infarcts. It is now well established that a majority of sequelae associated with human rickettsioses are the outcome of'Rickettsial vasculitis' 8 . Especially affects skeletal muscles, skin, lungs, kidneys, brain and cardiac muscles. This can also cause venous thrombosis and peripheral gangrene.
Central nervous system manifestations are mainly due to endothelial cell damage, vasculitis , inflammatory cell infiltration, typhus nodules, new endothelial cell proliferation, thrombosis, ischemia & infarction 9 and intracranial hemorrhages are most likely due to vasculitis and perivasculitis accompanied by disseminated endothelial destruction in the capillaries caused by o.tsutsugamushi 10 . Illness varies from mild and self limiting to fatal disease. Symptoms and signs vary in individuals with different strains. Commonest symptom high grade fevers, headache muscle pain, cough, and GI symptoms. Severe disease occurs in 2nd week with meningitis, meningo-encephalitis, deafness, pneumonia, ARDS, Multiorgan dysfunction & myocarditis. Reinfection & Relapses are seen due to variable immunity to different strains. Clinical signs are mainly rash, eschar, lympadenopathy, facial puffiness conjunctival suffusion, spleenomegaly, hepatospleenomegaly, pallor, icterus, ascites & rarely focal neurological deficit. Diagnosis depends on the clinical, epidemiological, serological, isolation & genetic assays 11 . Treatment is with doxycycline 100mg 1bd/tetracycline 500mg qid/ chlormycetin 500 mg qid/chloramphenicol for 7-15 days. Azithromycin 500mg 1OD for 3 days especially in pregnant women & children. Rifampicin 600/900mg once a day for one week in resistant cases.
IV.
Learning Points:
